v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
shares in Thousands, $ in Thousands
Total
Juvenescence Limited
Series A Convertible Preferred Stock
Common Stock
At The Market Sales Agreement
Common Stock
Private Placement
Common Stock
Private Placement and Reclassification of Tranche Liability
Common Stock
Series A Convertible Stock Conversion
Common Stock
Exercise of Pre-Funded Warrants, Private Placement
Preferred Stock
Series A Convertible Preferred Stock
Preferred Stock
Common Stock
Series A Convertible Stock Conversion
Preferred Stock
Series A Convertible Preferred Stock
Common Stock
Common Stock
Juvenescence Limited
Common Stock
Common Stock
At The Market Sales Agreement
Common Stock
Common Stock
Private Placement
Common Stock
Common Stock
Private Placement and Reclassification of Tranche Liability
Common Stock
Common Stock
Series A Convertible Stock Conversion
Common Stock
Common Stock
Exercise of Pre-Funded Warrants, Private Placement
Additional Paid-In Capital
Additional Paid-In Capital
Juvenescence Limited
Additional Paid-In Capital
Common Stock
At The Market Sales Agreement
Additional Paid-In Capital
Common Stock
Private Placement
Additional Paid-In Capital
Common Stock
Private Placement and Reclassification of Tranche Liability
Additional Paid-In Capital
Common Stock
Series A Convertible Stock Conversion
Accumulated Other Comprehensive Loss
Accumulated Deficit
Noncontrolling Interest
Beginning balance preferred stock (in shares) at Dec. 31, 2024                     0                                
Beginning balance at Dec. 31, 2024 $ 508                   $ 0 $ 1             $ 44,958             $ (44,318) $ (133)
Beginning balance common stock (in shares) at Dec. 31, 2024                       9,422                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                      
Issuance of common stock upon exercise of stock options (in shares)                       10                              
Issuance of common stock upon exercise of stock options 1                                   1                
Issuance of stock (in shares)                         500                            
Issuance of stock   $ 4,916                                   $ 4,916              
Stock-based compensation 956                                   956                
Net loss (4,822)                                                 (4,813) (9)
Ending balance preferred stock (in shares) at Mar. 31, 2025                     0                                
Ending balance at Mar. 31, 2025 1,559                   $ 0 $ 1             50,831             (49,131) (142)
Ending balance common stock (in shares) at Mar. 31, 2025                       9,932                              
Beginning balance preferred stock (in shares) at Dec. 31, 2024                     0                                
Beginning balance at Dec. 31, 2024 508                   $ 0 $ 1             44,958             (44,318) (133)
Beginning balance common stock (in shares) at Dec. 31, 2024                       9,422                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                      
Foreign currency translation adjustment 0                                                    
Net loss (11,284)                                                    
Ending balance preferred stock (in shares) at Jun. 30, 2025                     965                                
Ending balance at Jun. 30, 2025 1,646                   $ 4,940 $ 1             52,440             (55,579) (156)
Ending balance common stock (in shares) at Jun. 30, 2025                       10,145                              
Beginning balance preferred stock (in shares) at Mar. 31, 2025                     0                                
Beginning balance at Mar. 31, 2025 1,559                   $ 0 $ 1             50,831             (49,131) (142)
Beginning balance common stock (in shares) at Mar. 31, 2025                       9,932                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                      
Issuance of common stock upon exercise of stock options (in shares)                       42                              
Issuance of common stock upon exercise of stock options 1                                   1                
Issuance of stock (in shares)                 965         124                          
Issuance of stock     $ 4,940 $ 629         $ 4,940                       $ 629            
Issuance of common stock to consultant for services rendered (in shares)                       42                              
Issuance of common stock to consultant for services rendered 60                                   60                
Release of restricted stock units to consultant for services rendered (in shares)                       5                              
Release of restricted stock units to consultant for services rendered 29                                   29                
Stock-based compensation 890                                   890                
Foreign currency translation adjustment 0                                                    
Net loss (6,462)                                                 (6,448) (14)
Ending balance preferred stock (in shares) at Jun. 30, 2025                     965                                
Ending balance at Jun. 30, 2025 $ 1,646                   $ 4,940 $ 1             52,440             (55,579) $ (156)
Ending balance common stock (in shares) at Jun. 30, 2025                       10,145                              
Beginning balance preferred stock (in shares) at Dec. 31, 2025 965               965                                    
Beginning balance at Dec. 31, 2025 $ (37)               $ 4,940     $ 1             58,536           $ (14) (63,500)  
Beginning balance common stock (in shares) at Dec. 31, 2025 10,767                     10,767                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                      
Issuance of common stock upon exercise of stock options (in shares)                       138                              
Issuance of common stock upon exercise of stock options $ 8                                   8                
Issuance of stock (in shares)                           3,109 422 444                      
Issuance of stock       $ 10,169 $ 11,598 $ 1,705                             $ 10,169 $ 11,598 $ 1,705        
Issuance of common stock for Series A Convertible Preferred stock dividends (in shares)                       19                              
Stock-based compensation 1,077                                   1,077                
Foreign currency translation adjustment 6                                               6    
Net loss (6,898)                                                 (6,898)  
Ending balance preferred stock (in shares) at Mar. 31, 2026                 965                                    
Ending balance at Mar. 31, 2026 $ 17,628               $ 4,940     $ 1             83,093           (8) (70,398)  
Ending balance common stock (in shares) at Mar. 31, 2026                       14,899                              
Beginning balance preferred stock (in shares) at Dec. 31, 2025 965               965                                    
Beginning balance at Dec. 31, 2025 $ (37)               $ 4,940     $ 1             58,536           (14) (63,500)  
Beginning balance common stock (in shares) at Dec. 31, 2025 10,767                     10,767                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                      
Issuance of common stock upon exercise of stock options (in shares) 148                                                    
Foreign currency translation adjustment $ 14                                                    
Net loss $ (13,254)                                                    
Ending balance preferred stock (in shares) at Jun. 30, 2026 0               0                                    
Ending balance at Jun. 30, 2026 $ 18,730               $ 0     $ 3             95,481           0 (76,754)  
Ending balance common stock (in shares) at Jun. 30, 2026 25,400                     25,400                              
Beginning balance preferred stock (in shares) at Mar. 31, 2026                 965                                    
Beginning balance at Mar. 31, 2026 $ 17,628               $ 4,940     $ 1             83,093           (8) (70,398)  
Beginning balance common stock (in shares) at Mar. 31, 2026                       14,899                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                      
Issuance of common stock upon exercise of stock options (in shares)                       10                              
Issuance of stock (in shares)                   (965)         89   2,222 8,161                  
Issuance of stock         $ 6,397   $ 0 $ 1   $ (4,940)             $ 1 $ 1       $ 6,397   $ 4,939      
Issuance of common stock for Series A Convertible Preferred stock dividends (in shares)                       19                              
Stock-based compensation 1,051                                   1,051                
Foreign currency translation adjustment 8                                               8    
Net loss $ (6,356)                                                 (6,356)  
Ending balance preferred stock (in shares) at Jun. 30, 2026 0               0                                    
Ending balance at Jun. 30, 2026 $ 18,730               $ 0     $ 3             $ 95,481           $ 0 $ (76,754)  
Ending balance common stock (in shares) at Jun. 30, 2026 25,400                     25,400